Galectins & Alpha-Synuclein

Galectins proteins bind to sugar molecules and mediate the cellular response to endocytic vesicles. It is believed that some galectin proteins are involved in microglia activation induced by α-synuclein. Here is the latest research on galectins and alpha-synuclein.

September 20, 2020
Review

Potential human transmission of amyloid β pathology: surveillance and risks

Lancet Neurology
Elsa LauwersBart De Strooper
September 5, 2020
Open Access

Molecular basis for N-terminal alpha-synuclein acetylation by human NatB

ELife
Sunbin DengRonen Marmorstein
September 15, 2020

Perturbation of in vivo Neural Activity Following α-Synuclein Seeding in the Olfactory Bulb

Journal of Parkinson's Disease
Aishwarya S KulkarniDaniel W Wesson
September 6, 2020

Reduction of Lewy Body Pathology by Oral Cinnamon

Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology
Sumita RahaKalipada Pahan
September 15, 2020

Squalamine Restores the Function of the Enteric Nervous System in Mouse Models of Parkinson's Disease

Journal of Parkinson's Disease
Christine L WestWolfgang A Kunze
September 15, 2020
Open Access

Rational design of small molecules able to inhibit α-synuclein amyloid aggregation for the treatment of Parkinson's disease

Journal of Enzyme Inhibition and Medicinal Chemistry
Serena VittorioLaura De Luca
September 8, 2020

Wedelolactone Mitigates Parkinsonism Via Alleviating Oxidative Stress and Mitochondrial Dysfunction Through NRF2/SKN-1

Molecular Neurobiology
Shruti SharmaRakesh Pandey
September 16, 2020

Changes in the cellular fatty acid profile drive the proteasomal degradation of α-synuclein and enhance neuronal survival

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Mary XylakiEvangelia Emmanouilidou
September 15, 2020

Alpha-Synuclein Aggregates Associated with Mitochondria in Tunnelling Nanotubes

Neurotoxicity Research
Dario ValdinocciDean L Pountney
September 5, 2020

Effects of Subthalamic Deep Brain Stimulation With Different Frequencies in a Parkinsonian Rat Model

Neuromodulation : Journal of the International Neuromodulation Society
Zhimin LiRenzhi Wang
September 21, 2020

Neuronal Differentiation of LUHMES Cells Induces Substantial Changes of the Proteome

Proteomics
Johanna TüshausStefan F Lichtenthaler
September 18, 2020

Gut microbiota dynamics in Parkinsonian mice

ACS Chemical Neuroscience
Emily KlannVinata Vedam-Mai
September 11, 2020
Open Access

Immunotherapies Targeting α-Synuclein in Parkinson Disease

Federal Practitioner : for the Health Care Professionals of the VA, DoD, and PHS
Fariha Jamal
September 15, 2020

Phosphorylated Alpha-Synuclein Within Cutaneous Autonomic Nerves of Patients With Parkinson's Disease: The Implications of Sample Thickness on Results

The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
Ningshan WangChristopher H Gibbons
September 19, 2020

A facile impedimetric analysis of neuronal exosome markers in Parkinson's disease diagnostics

Analytical Chemistry
Ying FuJason J Davis

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/galectins-alpha-synuclein/a6062224-917a-497d-9fa9-90942e2f5c2f